Comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea, and anorexia: A single-blind, randomized, crossover study

Current Therapeutic Research - Clinical and Experimental

Volumn 61, Issue 12, 2000, Pages 901-909

  Feng, Feng Yi ^a   Zhang, Pin ^a   He, You Jian ^b   Li, Yu Hong ^b   Zhou, Mei Zhen ^c   Cheng, Gang ^c   Yamamoto, Minoru ^d  

^a CANCER HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d ASTELLAS PHARMA INC   (Japan)

Author keywords

5HT3 receptor antagonist; Anorexia; Chemotherapy induced emesis; Granisetron; Nausea; Ramosetron

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; DOXORUBICIN; GRANISETRON; RAMOSETRON; SEROTONIN 3 ANTAGONIST;

ADOLESCENT; ADULT; AGED; ANOREXIA; ANTIEMETIC ACTIVITY; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RATING SCALE; TREATMENT OUTCOME;

EID: 0034528844     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(00)90017-1     Document Type: Article

References (15)

1. Mechanisms of vomiting induced by serotonin-3 receptor agonists in the cat: Effect of vagotomy, splanchnicectomy or area postrema lesion
2. Mechanisms of cisplatin- and m-chlorophenylbiguanide-induced emesis in ferrets
3. Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: A multicentre double-blind, randomised, parallel-group study
4. Clinical phase III study of YM060 injection on anticancer drug-induced nausea and vomiting. Double blind comparative study versus placebo
5. 3 receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting
6. GR38032F (GR-C507/75): A novel compound effective in the prevention of acute cisplatin-induced emesis
7. 3 receptor antagonist, and its enantiomer in the isolated tissue
8. 3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells
9. 3 receptor antagonist, on 5-HT-induced Bezold-Jarisch reflex in ferrets
10. 3 receptor antagonist, on cisplatin-induced emesis in ferrets
11. Clinical phase III study of YM060 injection on anticancer drug, cisplatin-induced nausea and vomiting
12. Clinical evaluation of YM060 injection on chemotherapy-induced nausea and emesis. Studies on preventive administration method
13. Clinical evaluation of granisetron against nausea and vomiting induced by anticancer drugs. Optimal dose-finding study
14. Clinical PI study of YM060
15. Phase I study of granisetron. Pharmacokinetics of granisetron following single and repeat intravenous drip infusion in Japanese healthy volunteers